Depression is a health issue that has been left untreated by a lot of people. Unfortunately, not too many take this as seriously as they should, and this is the reason why this is happening. Check out the latest reports about how you can treat depression these days.
Depression and psychedelics?
It’s been revealed that for a long time, scientists have been looking ever more seriously at the therapeutic effect of psychedelics. As you probably know by now, these are not legal under US federal law. On the other hand, despite this renewed interest, large-scale studies are still lacking, according to the latest reports.
Now, experts have taken an important step to fill this gap.
Their work has been published in the New England Journal of Medicine. It’s important to note the fact that this is the largest clinical trial ever conducted to evaluate the effect of psilocybin. This is a psychoactive substance found naturally in “magic” mushrooms. Here are the notes as they are revealed in the original; article:
“A single dose of 25 milligrams reduced symptoms of depression in people for whom several conventional treatments had failed, they showed. An estimated 100 million people worldwide suffer from treatment-resistant depression. Some experts view psychedelics as a possible way to help them.”
Check out the original notes in order to learn more details about all this.
Depression in the news
Not too long ago, we revealed that German researchers have demonstrated that treatment for depression can result in a boost in brain connection, and patients who respond favorably to this medication exhibit a higher increase in connectivity than those who do not respond favorably to this treatment.
This indicates that the brain structure of people with major clinical depression is not as permanent as we assumed and that we can enhance cognitive structure within a relatively short time frame, approximately six weeks.
